文献速递妇科生殖医学

经阴道自然腔道内镜手术行卵巢组织活检用于冷冻保存:一种微创卵巢活检新方法

Ovarian tissue biopsy for cryopreservation by vaginal natural orifice transluminal endoscopic surgery: a new approach for a minimal invasive ovarian biopsy.
PubMed 文献 · Fertil Steril · 2024-04-09

本文以视频加文字分步演示的方式,报告一例27岁低级别滤泡性非霍奇金淋巴瘤患者经阴道自然腔道内镜手术(vNOTES)行卵巢组织活检冷冻保存。手术经3 cm后穹窿切开入路,切除左卵巢70%组织,总手术时间25分钟,无术中及术后并发症,术后24小时出院。作者认为vNOTES可能成为腹腔镜行卵巢组织冷冻保存的可行替代入路,但需进一步更大规模研究评估其有效性与安全性。

要点

  • 27岁低级别滤泡性非霍奇金淋巴瘤患者化疗前经vNOTES行卵巢组织活检冷冻保存
  • 经3 cm后穹窿切开建立入路,切除左卵巢70%,总手术时间25分钟
  • 无术中及术后并发症,术后24小时出院

核心结论

  • 作者认为vNOTES可能成为腹腔镜行卵巢组织冷冻保存的可行替代入路,可方便到达卵巢并切除不同体积的组织。
  • 作者认为接受卵巢冷冻保存的患者可能从vNOTES入路获益,因为术后快速恢复对短期启动化疗至关重要。
  • 作者认为与其他vNOTES手术一样,准确选择患者似乎对成功完成卵巢组织冷冻保存至关重要。
  • 作者认为其他经vNOTES完成的妇科手术所报告的纳入与排除标准可能同样适用于经vNOTES行卵巢组织冷冻保存。
  • 作者指出需进一步更大规模研究评估这一新入路的有效性与安全性。

研究设计与样本

  • 本文为手术操作的分步文字说明与配音视频演示。
  • 研究在三级转诊学术中心完成。
  • 患者为1例27岁、新诊断低级别滤泡性非霍奇金淋巴瘤、化疗前转诊行卵巢组织冷冻保存的女性。
  • 因研究性质,无需机构审查委员会批准;患者已签署知情同意,同意视频发表及在社交媒体、期刊网站、科学文献网站(如PubMed、ScienceDirect、Scopus)及其他适用网站发布。

主要发现

  • 手术经3 cm后穹窿切开进入腹腔,使用GelPOINT Mini Advanced Access Platform(Applied Medical,Rancho Santa Margarita,CA)作为vNOTES端口,含1个10 mm和2个5 mm穿刺器。
  • 气腹压力设为8 mm Hg,手术台倾斜至20°头低脚高位,置入10 mm刚性30°摄像头。
  • 用冷剪刀切除左卵巢70%以减少对手术标本的创伤,随后用双极器械凝血卵巢。
  • 术中及术后均未报告并发症,患者术后24小时出院。
  • 总手术时间为25分钟;输卵管通畅试验中观察到蓝色染料通过双侧输卵管。

关键数值与推荐

  • 卵巢组织冷冻保存的纳入标准为年龄<35岁、因中等或高卵巢早衰(POI)风险且5年生存机会好而无法延迟肿瘤治疗以行卵泡冷冻保存的女性。
  • 卵巢活检体积范围为:中等POI风险女性切除卵巢的50%,高风险女性切除70%-100%。
  • 若肿瘤治疗包括子宫照射或存在卵巢转移风险的肿瘤(如卵巢癌、白血病、神经母细胞瘤或伯基特淋巴瘤),则不能行卵巢组织冷冻保存。
  • 作者认为盆腔粘连高风险女性(如合并子宫内膜异位症、既往盆腔手术或盆腔炎性疾病)、体重指数升高或子宫增大者、以及宫颈、阴道或子宫癌患者不能考虑此入路,因为这些因素均与vNOTES失败相关。
  • 作者认为无手术史、无子宫内膜异位症及无大的子宫肌瘤的女性可能从vNOTES入路获益,而这些女性构成接受卵巢组织冷冻保存患者的大多数。

临床怎么用

  • 作者认为vNOTES可能为腹腔镜行卵巢组织冷冻保存的可行替代入路,可方便到达卵巢并切除不同体积的组织。
  • 作者认为接受卵巢冷冻保存的患者可能从vNOTES入路获益,因为术后快速恢复对短期启动化疗至关重要。
  • 作者认为与其他vNOTES手术一样,准确选择患者似乎对成功完成卵巢组织冷冻保存至关重要。
  • 作者认为其他经vNOTES完成的妇科手术所报告的纳入与排除标准可能同样适用于经vNOTES行卵巢组织冷冻保存。
  • 作者指出需进一步更大规模研究评估这一新入路的有效性与安全性。

局限性

  • 作者指出需进一步更大规模研究评估这一新入路的有效性与安全性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Vaginal natural orifice transluminal endoscopic surgery (vNOTES) is an emerging surgical procedure that combines the advantages of the vaginal approach with laparoscopic vision and instrumentation. Shorter hospitalization and lesser postoperative pain associated with vNOTES may be explained by the advantages of this innovative surgical approach (e.g., absence of abdominal incisions, shorter operative time, and lower insufflation pressure). Ovarian tissue cryopreservation allows to preserve reproductive and endocrine functions in young women with oncological disease at risk of premature ovarian insufficiency (POI) caused by gonadotoxic treatments. Ovarian tissue biopsy for cryopreservation consists of a large biopsy of 1 or both ovaries that is usually performed by laparoscopy. Then, the removed ovarian tissue is cryopreserved for the future transplant after cancer remission. The volume of ovarian biopsy ranges from 50% of the ovary for women at moderate risk of POI to 70%-100% of it for those at high risk. The inclusion criteria for ovarian tissue cryopreservation are women aged <35 years who cannot delay start of oncological treatments for follicle cryopreservation, with a moderate or high risk of POI and good chance of 5-year survival. Ovarian tissue cryopreservation cannot be performed if tumor treatments include uterine irradiation or for tumors at risk of ovarian metastases (as in the case of ovarian cancer, leukemia, neuroblastoma, or Burkitt lymphoma). Despite widespread adoption of vNOTES in gynecology, ovarian biopsy for cryopreservation has never been performed using this route. DESIGN: Step-by-step explanation of the procedure with descriptive text and narrated video footage. SETTING: Tertiary-level referral academic center. PATIENT(S): A 27-year-old patient recently diagnosed with low-grade follicular non-Hodgkin lymphoma was referred to our center for ovarian tissue cryopreservation before chemotherapy. The patient included in this study gave informed consent for publication of the video and posting of the video online including social media, the journal website, scientific literature websites (e.g., PubMed, ScienceDirect, and Scopus), and other applicable sites. Because of the nature of the study, institutional review board approval was not required. INTERVENTION(S): Access to the peritoneal cavity was created by a 3-cm posterior colpotomy. The peritoneum was then opened using cold scissors and temporarily fixed to the posterior vaginal wall. The GelPOINT Mini Advanced Access Platform (Applied Medical, Rancho Santa Margarita, CA), with 1 10-mm and 2 5-mm trocars, was used as the vNOTES port. The inner Alexis ring of the GelPOINT was inserted through the colpotomy into the pouch of Douglas. A hysterometer was placed into the uterine cavity to keep the uterus anteverted during the surgery. A pneumoperitoneum was created to a pressure of 8 mm Hg, and the operating table was tilted to a 20° Trendelenburg position. A 10-mm rigid 30° camera was inserted in the inferior and larger trocar, and both ovaries were visualized. Seventy percent of the left ovary was removed with cold scissors to minimize trauma on the surgical specimen. After removal of the GelPOINT cap, ovarian biopsy was immediately picked up by the biologist of our fertility center. The ovary was coagulated with a bipolar instrument. The hysterometer was then replaced by a uterine manipulator to perform tubal patency test, and blue dye passage through both salpinges was observed. Finally, the Alexis retractor and stich on the posterior peritoneum were removed, and the vagina was sutured using interrupted stiches. The total operative time was 25 minutes. MAIN OUTCOMES MEASURE(S): Ovarian tissue biopsy for cryopreservation by vNOTES. RESULT(S): No intraoperative and postoperative complications were reported, and the patient was discharged after 24 hours from surgery. CONCLUSION(S): Vaginal natural orifice transluminal endoscopic surgery may be a feasible alternative approach to laparoscopy for ovarian tissue cryopreservation: it allows an easy access to the ovaries and removal of different tissue volumes. Patients undergoing ovarian cryopreservation may benefit from the vNOTES approach because a rapid postoperative recovery is crucial to start chemotherapy in a short time. As for other vNOTES procedures, accurate selection of patients seems to be crucial for a successful ovarian tissue cryopreservation. We believe that the inclusion and exclusion criteria reported for other gynecologic procedures performed through vNOTES may also be valid for ovarian tissue cryopreservation by vNOTES. Women at high risk of pelvic adhesions (e.g., coexistent endometriosis, previous pelvic surgery, or inflammatory pelvic disease), those with an increased body mass index or enlarged uterus, and those with cervical, vaginal, or uterine cancer cannot be considered for this approach because all these factors are associated with failure of vNOTES. On the other hand, women with no history of surgery, endometriosis, and large myomas may benefit from the vNOTES approach, and these women represent most of patients who undergo ovarian tissue cryopreservation. Further and larger studies are needed to assess the efficacy and safety of this new approach.

来源:Fertil Steril,查看原文。版权归原作者所有。

引用

  1. Seracchioli R, Maletta M, Pazzaglia E, et al. Ovarian tissue biopsy for cryopreservation by vaginal natural orifice transluminal endoscopic surgery: a new approach for a minimal invasive ovarian biopsy. Fertil Steril. 2024. PMID: 38604263. doi:10.1016/j.fertnstert.2024.04.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。